Bellerophon Therapeutics, Inc.·4

Jan 28, 4:30 PM ET

Shah Parag Suresh 4

4 · Bellerophon Therapeutics, Inc. · Filed Jan 28, 2022

Insider Transaction Report

Form 4
Period: 2022-01-26
Shah Parag Suresh
VP Proj Mgmt & Distribution
Transactions
  • Award

    Restricted Stock Units

    2022-01-26+51,00051,000 total
    Exercise: $0.00Common Stock (51,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.
  • [F2]Not applicable.

Documents

1 file
  • 4
    form4-01282022_040108.xmlPrimary